P2-receptors
mediate the actions of extracellular nucleotides such
as ATP or UTP. The receptors play a physiological or pathophysiological
role in a variety of tissues or cells. This includes vasoconstriction due to
sympathetic nerve stimulation, blood platelet aggregation, pain transmission
and chloride ion secretion in airway epithelia. Two families of P2-receptors
are known: P2X-receptors, which represent a totally new class of ligand-gated ion channels with two transmembrane
domains, and P2Y-receptors, which belong to the superfamily
of G-protein coupled receptors with seven transmembrane
domains (e.g., see the predicted secondary structure
of the human P2Y6-receptor).
Updated August 2007.
(see reviews von
Kügelgen I, 2006, Pharmacological profiles of cloned
mammalian P2Y-receptor subtypes, Pharmacology & Therapeutics 110:415-432.
Epub 2005 Oct 28.
and: von Kügelgen I and Wetter A, 2000, Molecular pharmacology of
P2Y-receptors, Naunyn-Schmiedeberg“s Archives of
Pharmacology 362:310-323; published online DOI 10.1007/s002100000310).
Cloned and functionally expressed
P2Y-subtypes:
P2Y1,
P2Y2,
P2Y3,
P2Y4,
P2Y6,
p2y8,
P2Y11,
P2Y12,
P2Y13,
tp2y,
P2Y14(UDP-Glucose)
(for nomenclature see comments in von Kügelgen
and Wetter, 2000, Naunyn-Schmiedeberg“s Archives of
Pharmacology 362:310-323)
|
P2 Receptor Subtype |
Species |
Tissue Distribution |
Cloned from |
Genbank Accession N° |
Selected References |
Principle Agonists |
Selected References |
Principle Antagonists (pA2 or pKB) |
Selected References |
|
|
|||||||||
|
Human |
Wide including platelets, heart, skeletal muscle, neuronal tissue,
digestive tract |
Blood Platelets |
2_Methylthio_ADP> ADP> 2_Methylthio_ATP>
ATP |
MRS2179 (6.75)
Reactive
blue 2 (6.1) Suramin (5.5) PPADS
(5.4-4.9) |
Guo et al. 1999 |
||||
|
Whole Blood |
Leon et al. 1998 (direct submission) |
||||||||
|
Erythro leukaemia cells |
|||||||||
|
Genomic DNA |
|||||||||
|
Erythro leukaemia cells |
|||||||||
|
Erythro leukaemia cells |
|||||||||
|
Placenta |
|||||||||
|
Mouse |
See above |
Insulinoma cells |
2_Methylthio_ATP> 2-Chloro-ATP > ATP |
No data |
No data |
||||
|
Embryonic stem cells |
Leon 1999 (direct submission) |
||||||||
|
Rat |
See above |
Insulinoma cells |
2_Methylthio_ADP = 2_Methylthio_ATP
> ADP > ATP |
PPADS (5.5) |
|||||
|
Bovine |
See above |
Corpus Callosum, glial cells |
2_Methylthio_ATP > ATP |
No data |
No data |
||||
|
Aortic endothelial cells |
|||||||||
|
Chicken |
See above |
Brain |
2_Methylthio_ATP > ATP > ADP |
Suramin (decrease by 100 % at 100
µM) Reactive
blue 2 (decrease by 100 % at 100 µM) |
|||||
|
Turkey |
See above |
Brain |
2_Methylthio_ATP > ATP > ADP |
MRS2179 (6.99) PPADS (5.98) Suramin (5.75) |
|||||
|
Human |
Wide including lung, heart, skeletal muscle, spleen, kidney |
Airway epithelium, epithelial cell, CF/T43 cells |
UTP = ATP > Ap4A > ATP |
Suramin (4.3) |
|||||
|
Airway epithelium, epithelial cell, CF/T43 cells |
|||||||||
|
Mouse |
See above |
Neuro-blastoma cells, NG108-15 cells |
UTP = ATP > Ap4A |
No data |
No data |
||||
|
Rat |
See above |
Pituitary |
UTP = ATP |
No data |
No data |
||||
|
Alveolar type II cell |
|||||||||
|
Smooth muscle cell cDNA library |
|||||||||
|
Chicken |
Spleen, kidney, CNS |
Brain |
ADP > UTP > UDP |
Reactive blue 2 (decrease by 100 % at 100 µM) Suramin (5.4) |
|||||
|
Turkey |
See above |
Genomic DNA |
UDP > 5-Bromo-UDP > 2_Methylthio_ADP >
ADP |
No data |
No data |
||||
|
Human |
Placenta, lung, vascular smooth muscle |
Genomic DNA |
UTP > UTPgS >> ATP,
UDP |
PPADS (decrease by 30-73 % at 100 µM) Reactive
blue 2 (decrease by 33 % at 100 µM) |
|||||
|
Chromosome X |
|||||||||
|
Genomic DNA |
|||||||||
|
Pancreas |
|||||||||
|
Rat |
See above |
Brain |
UTP = ATP = ITP = Ap4A |
Reactive blue 2 (decrease by 100 % at 100 µM) |
|||||
|
Liver |
Bogdanov et al. 1997 (direct
submission) |
||||||||
|
Mouse |
See above |
N.I. |
Suarez-Huerta et al. 2000 (direct submission) |
No data |
No data |
No data |
No data |
||
|
N.I. |
Suarez-Huerta et al. 2000 (direct submission) |
||||||||
|
Human |
Wide including lung, heart, aorta, spleen, placenta, thymus,
intestine, brain |
Placenta |
UDP = 5-Bromo-UDP >> UTP > 2_Methylthio_ADP
|
Reactive blue 2 (6.0) PPADS
(decrease by 69 % at 100 µM) |
|||||
|
Placenta |
|||||||||
|
Placenta |
|||||||||
|
Placenta |
|||||||||
|
Stimulated T-lymphocyte |
Hammet et al. 1996 (direct
submission) |
||||||||
|
N.I. |
Communi et al. 1996 (direct
submission) |
||||||||
|
Rat |
See above |
Aortic smooth muscle cells |
UDP > UTP > ADP > 2_Methylthio_ATP |
Reactive blue 2 (decrease by 77 % at 100 µM) |
|||||
|
Xenopus laevis |
Neural plate |
Neural plate |
UTP = CTP = ATP = ITP = GTP |
Suramin (decrease by 100 % at 100
µM) |
|||||
|
Human |
Spleen, intestine, immunocytes |
Placenta |
ATPgS = Benzoyl-Benzoyl-ATP
> ATP > 2_Methylthio_ATP |
Suramin (6.09) Reactive
blue 2 (decrease by 80 % at 100 µM) |
|||||
|
Placenta |
|||||||||
|
Human |
Platelets, brain |
Platelets |
Hollopeter et al. 2001, Takasaki et al. 2001, Zhang et al. 2001 |
2_Methylthio_ADP > ADP |
Hollopeter et al. 2001, Takasaki et al. 2001, Zhang et al. 2001 |
AR-C69931MX >> 2_Methylthio-AMP |
Hollopeter et al. 2001, Takasaki et al. 2001, Zhang et al. 2001 |
||
|
Rat |
See above |
Platelets |
See above |
2_Methylthio-AMP |
|||||
|
Human |
Spleen, leucocytes, bone marrow, placenta, liver, brain |
Spleen, neutrophil granulocytes |
2_Methylthio_ADP = ADP > ADPbS > IDP |
No blockade by MRS2179 3 µM |
|||||
|
Mouse |
Spleen, leucocytes, liver, brain |
Spleen |
2_Methylthio_ADP = ADP = ADPbS = IDP |
No data |
No data |
||||
|
Turkey |
No data |
Blood |
UTP = ATP > Ap4A > ATPgS |
No data |
No data |
||||
|
Human |
No data |
Myeloblast |
UDP-Glucose |
No data |
No data |
||||
|
Rat |
No data |
N.I. |
UDP-Glucose |
|
No data |
No data |
|||
Ap4A, diadenosine-tetraphosphate; ATPgS, adenosine-thiotriphosphate;
N.I., no information; UTPgS, uridine-thiotriphosphate.
* The
P2Y14-receptor was previously named UDP-Glucose receptor (for nomenclature see Abbracchio et al., 2003, Trends Pharmacol
Sci 24:52-55)